Skip to content

Prospective study of diverting loop ileostomy in rectal cancer surgery

Prospective study of diverting loop ileostomy in rectal cancer surgery - Prospective study of diverting loop ileostomy in rectal cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038150
Enrollment
350
Registered
2019-09-30
Start date
2015-07-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

None listed

Sponsors

Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with rectal cancer who will have diverting loop ileostomy. 2) Surgery is AR / LAR / ISR. 3) No history of surgery with intestinal resection (except for appendectomy). 4) No history of intestinal obstruction. 5) Age at the time of registration is 20 years or older. 6) Operable general condition, organ function. 7) Performance Status (ECOG) is either 0 or 1. 8) A written consent has been obtained from the patient for participation in the study.

Exclusion criteria

Exclusion criteria: 1) Cases with the following serious complications 1: Poorly controlled diabetes 2: Uncontrolled heart failure, angina, hypertension, and arrhythmia 3: Interstitial pneumonia, pulmonary fibrosis, advanced emphysema 4: Continuous systemic administration of steroids. 2) Patients with psychosis are considered inappropriate to participate in this study. 3) Cases without a written consent. 4) Cases judged as inappropriate by doctors.

Design outcomes

Primary

MeasureTime frame
To evaluate the rate of intestinal obstruction.

Secondary

MeasureTime frame
To evaluate fasting period, period until start of oral ingestion after surgery, nasal tube insertion period, period of tube insertion via ileostomy, necessity of operation for intestinal obstruction, the incidence of SSI, the rate of stoma-related morbidity, other postoperative complications, operation time, and bleeding volume.

Countries

Japan

Contacts

Public ContactMatsuda Chu

Osaka University Graduate School of Medicine Department of Gastroenterological Surgery

cmatsuda@gesurg.med.osaka-u.ac.jp06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026